Ignite Creation Date:
2024-05-06 @ 5:12 PM
Last Modification Date:
2024-10-26 @ 2:24 PM
Study NCT ID:
NCT05226143
Status:
COMPLETED
Last Update Posted:
2022-11-14
First Post:
2022-01-26
Brief Title:
A Study of an Eczema Spot Treatment in Providing Eczema Symptoms Relief and Lasting Itch Relief to Affected Skin Area
Sponsor:
Johnson Johnson Consumer Inc JJCI
Organization:
Johnson Johnson Consumer and Personal Products Worldwide
Study Overview
Official Title:
A Single Center Clinical Study to Determine the Safety and Efficacy of an Eczema Spot Treatment in Providing Eczema Symptoms Relief and Lasting Itch Relief to Affected Skin Area
Status:
COMPLETED
Status Verified Date:
2022-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy assessed by clinical evaluation of eczemaatopic lesion severity atopic dermatitis severity index ADSI scoring and perceived benefits in itch visual analog score VAS scoring and tolerability assessed by clinical grading of an investigational spot treatment Gel Cream when used on a target site of participants with mild to moderate atopic dermatitis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None